Prot # GS-US-342-1137: A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects with Chronic HCV Infection and Child-Pugh Class B Cirrhosis

  • Flamm, Steven L (PD/PI)

Project: Research project

Project Details

Effective start/end date7/14/147/13/17


  • PRA Health Sciences (Prot # GS-US-342-1137 // Prot # GS-US-342-1137)
  • Gilead Sciences, Inc (Prot # GS-US-342-1137 // Prot # GS-US-342-1137)